FdaApplication

ANDA 216992

Back to search

Identifiers

Properties

PropertyValue
applicant_nameUPSHER SMITH LABORATORIES LLC
application_typeANDA
approval_date2025-08-11

Products (1)

ProductActive ingredientStrengthDosage form
DEFLAZACORTDEFLAZACORT22.75MG/MLSUSPENSION;ORAL

1 product